معرفی
David Tetard is an Assistant Professor in the Applied Sciences Department at Northumbria University. His research focuses on designing novel iron (Fe) chelators with therapeutic applications in cancer, neurodegenerative diseases (e.g., Parkinson’s and Alzheimer’s), and antimicrobial agents. He holds a PhD in Chemistry (1996) and a PCAPL in Teaching & Learning (2008).
- Education:
- PhD in Chemistry (Northumbria University, 1993–1996)
- Postgraduate Certificate in Academic Practice in Learning & Teaching (2007–2008)
His research interests emphasize rational design of Fe(III) chelators from the hydroxypyridinone family, optimizing cell penetration and multifunctional drug action. Key projects include anticancer compounds targeting mitochondrial metabolism, neuroprotective agents against oxidative damage, and biostatic agents inhibiting microbial growth. Recent work demonstrates cytotoxic effects of the chelator SK4 in ovarian and breast cancer cell lines, while neuroprotective chelators show dual action in Parkinson’s disease models.
Publications span over 30 peer-reviewed articles, with a focus on chelator mechanisms in cancer and neurodegeneration. Collaborations include international teams studying drug efficacy and disease pathways. He accepts PhD students for projects in anti-cancer compounds, neurodegenerative disease molecules, and antimicrobial chelators.
Labs and teams: Active in interdisciplinary research networks, though specific lab names are not detailed here.
